Researchers already knew that men and postmenopausal women have a higher risk of developing Parkinson’s disease than premenopausal women. Now, a recent study in mice concludes that estrogen may be responsible. The authors also hope that estrogen might form the basis of future treatments.
The scientists suggest that estrogen treatment might be beneficial even after symptoms have started, which is important because spotting neurodegenerative conditions before symptoms arise is challenging. However, as always, the transition from an animal model to clinical trials in humans will be the making or breaking of this theoretical intervention.
The researchers hope that boosting estrogen in human brains might, one day, offer a way to slow Parkinson’s disease progression.
Story Source & Image Source: Medical News Today
Originally written by: Isabel Godfrey
Note: Content may be edited for style and length